Literature DB >> 9640241

In vivo exposure to Porphyromonas gingivalis up-regulates nitric oxide but suppresses tumour necrosis factor-alpha production by cultured macrophages.

I Frolov1, Y Houri-Hadad, A Soskolne, L Shapira.   

Abstract

The present study was designed to test whether the functional response of mouse macrophages elicited by chronic exposure to bacteria will be different from that of cells elicited by a non-bacterial irritant. Macrophage elicitation was conducted by Porphyromonas gingivalis, a major periodontal pathogen, in comparison to a standard elicitation by thioglycollate (TG). We measured lipopolysaccharide (LPS)-induced nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) secretion by the elicited macrophages, and the expression of inflammatory cytokines in the whole elicited cell population. In addition, we tested the response of TG-elicited macrophages to pretreatment with P. gingivalis LPS in vitro. Mouse peritoneal macrophages were harvested 4 days after intraperitoneal injection of TG or heat-killed P. gingivalis. TG-elicited macrophages produced undetectable levels of TNF-alpha and approximately 0.5 microM of NO. The stimulation of the macrophages with LPS resulted in the secretion of NO and TNF-alpha in a dose-dependent manner. The P. gingivalis-elicited macrophages produced basal levels of approximately 5 microM NO, but TNF-alpha was not detectable. LPS stimulation of these cells further increased the secretion of NO eightfold while TNF-alpha remained undetectable. The NO secretion by P. gingivalis-elicited cells was significantly higher than that by TG-elicited cells. Examination of cytokine expression in the whole elicited cell population revealed that both P. gingivalis-elicited cells and TG-elicited cells expressed messenger RNA for interleukin-2 (IL-2), TNF-alpha and interferon-gamma (IFN-gamma), but not for IL-4. IL-6 was expressed in P. gingivalis-elicited cells only. Pretreatment of TG-elicited macrophages with P. gingivalis LPS for 24 hr prior to a second LPS challenge resulted in down-regulation of TNF-alpha secretion and up-regulation of NO secretion, a response similar to that seen in P. gingivalis-elicited peritoneal macrophages. The results suggest that the in vivo exposure of resident macrophages to P. gingivalis induces functional changes in peritoneal macrophages. These changes might be due to the effect of P. gingivalis LPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9640241      PMCID: PMC1364079          DOI: 10.1046/j.1365-2567.1998.00437.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

Authors:  K Selmaj; C S Raine; B Cannella; C F Brosnan
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

2.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

Review 3.  Secretory products of macrophages.

Authors:  C F Nathan
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

4.  Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization.

Authors:  K L MacNaul; N I Hutchinson; J N Parsons; E K Bayne; M J Tocci
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

5.  IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice.

Authors:  D Aderka; J M Le; J Vilcek
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

6.  Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures.

Authors:  D C Morrison; L Leive
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

7.  Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF.

Authors:  R Schindler; J Mancilla; S Endres; R Ghorbani; S C Clark; C A Dinarello
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

8.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

9.  Reduced alveolar macrophage production of tumor necrosis factor during sepsis in mice and men.

Authors:  S Q Simpson; H N Modi; R A Balk; R C Bone; L C Casey
Journal:  Crit Care Med       Date:  1991-08       Impact factor: 7.598

10.  Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components.

Authors:  L Kesavalu; J L Ebersole; R L Machen; S C Holt
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

View more
  4 in total

1.  Proinflammatory and antimicrobial nitric oxide in gingival fluid of diabetic patients with periodontal disease.

Authors:  Uros Skaleric; Boris Gaspirc; Nancy McCartney-Francis; Andrej Masera; Sharon M Wahl
Journal:  Infect Immun       Date:  2006-10-02       Impact factor: 3.441

2.  Repeat bacterial challenge in a subcutaneous chamber model results in augmented tumour necrosis factor-alpha and interferon-gamma response, and suppression of interleukin-10.

Authors:  Y Houri-Haddad; W A Soskolne; A Halabi; V Barak; L Shapira
Journal:  Immunology       Date:  2000-02       Impact factor: 7.397

3.  Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease.

Authors:  Stella Chaushu; Asaf Wilensky; Chamutal Gur; Lior Shapira; Moran Elboim; Gili Halftek; David Polak; Hagit Achdout; Gilad Bachrach; Ofer Mandelboim
Journal:  PLoS Pathog       Date:  2012-03-22       Impact factor: 6.823

Review 4.  Is the oral microbiome a source to enhance mucosal immunity against infectious diseases?

Authors:  Camille Zenobia; Karla-Luise Herpoldt; Marcelo Freire
Journal:  NPJ Vaccines       Date:  2021-06-02       Impact factor: 7.344

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.